(EMAILWIRE.COM, March 01, 2025 ) ๐๐๐ซ๐ค๐๐ญ ๐๐ฏ๐๐ซ๐ฏ๐ข๐๐ฐ:
The Global Breast Imaging Market was valued at US$ 4.74 billion in 2024 and is projected to reach US$ 9.77 billion by 2033, growing at a CAGR of 8.43% from 2025 to 2033. Breast imaging includes various diagnostic techniques aimed at visualizing and assessing breast tissue for abnormalities such as cysts, lumps, or cancer indicators. These imaging methods play a crucial role in early detection, diagnosis, and continuous monitoring, enabling timely medical intervention and effective treatment planning.
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐ ๐ซ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐: https://www.datamintelligence.com/download-sample/breast-imaging-market
๐๐๐ซ๐ค๐๐ญ ๐๐ซ๐๐ง๐๐ฌ:
๐๐๐๐ก๐ง๐จ๐ฅ๐จ๐ ๐ข๐๐๐ฅ ๐๐๐ฏ๐๐ง๐๐๐ฆ๐๐ง๐ญ๐ฌ ๐๐ซ๐ข๐ฏ๐ข๐ง๐ ๐๐ซ๐จ๐ฐ๐ญ๐ก
Continuous advancements in breast imaging technologies are significantly boosting market expansion by enhancing diagnostic accuracy and improving patient outcomes. Innovations such as digital mammography, 3D tomosynthesis, and AI-powered imaging have improved the detection of cancerous tissues, especially in dense breast tissue. For example, in August 2024, OSF HealthCare introduced the Invenia ABUS 2.0 (Automated Breast Ultrasound System) at its Saint Elizabeth Medical Center, enhancing breast cancer screening capabilities.
๐๐๐ซ๐ค๐๐ญ ๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง:
By Type: Screening Mammography, Diagnostic Mammography, Breast Tomosynthesis, Breast Ultrasound, Breast MRIs.
By Technology: Computed Tomography (CT) Scan, Magnetic Resonance Imaging (MRI) Scan, Ultrasound, Positron Emission Tomography (PET) Scan, Others.
By Application: Breast Disease, Breast Cancers, Benign Tumors, Cysts, Others.
By End-User: Hospitals, Diagnostic Centers, Research Institutes, Others.
By Region: North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.
๐๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐ ๐๐จ๐ฎ๐ซ ๐๐๐ฆ๐ฉ๐ฅ๐: https://www.datamintelligence.com/customize/breast-imaging-market
๐๐๐จ๐ ๐ซ๐๐ฉ๐ก๐ข๐๐๐ฅ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ:
๐๐จ๐ซ๐ญ๐ก ๐๐ฆ๐๐ซ๐ข๐๐ ๐๐๐๐๐ข๐ง๐ ๐ญ๐ก๐ ๐๐๐ซ๐ค๐๐ญ
North America is expected to maintain a dominant position in the global breast imaging market due to technological advancements, increasing awareness, and strong healthcare infrastructure. The adoption of 3D mammography, AI-powered imaging solutions, and MRI techniques continues to rise. Notable advancements include Seno Medical Instruments launching the Imagio Breast Imaging System in November 2022, integrating optoacoustic and ultrasound technologies for improved cancer detection.
Key players in the region are actively expanding their product portfolios and forming strategic partnerships. In December 2024, QT Imaging Holdings, Inc. expanded its Breast Acoustic CT Scanner to the Couri Center for Gynecology and Integrative Women’s Health in Peoria, IL, in collaboration with NXC Imaging, Inc. Such initiatives contribute to the increasing adoption of advanced imaging solutions in North America.
๐๐จ๐ฆ๐ฉ๐๐ญ๐ข๐ญ๐ข๐ฏ๐ ๐๐๐ง๐๐ฌ๐๐๐ฉ๐:
The breast imaging market is highly competitive, with major players focusing on research, product innovation, and strategic collaborations. Leading companies in the market include:
GE HealthCare
Koning Health
FUJIFILM Holdings Corporation
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Hologic, Inc.
Siemens Healthineers AG
Agfa-Gevaert Group.
Koninklijke Philips N.V.
Planmed Oy
Seno Medical
๐๐๐ฒ ๐๐๐ฏ๐๐ฅ๐จ๐ฉ๐ฆ๐๐ง๐ญ๐ฌ:
In August 2024, Izotropic Corporation announced plans to pursue regulatory approval in the U.S. and EU for IzoView, a diagnostic device designed for dense breast tissue imaging.
In June 2023, Koning Corporation introduced an AI-powered adjunctive software that enhances 3D CT breast imaging by integrating with the companyยs breast CT devices.
In January 2023, Izotropic Corporation revealed that IzoView would be featured on an “Advancements with Ted Danson” segment on Amazon Prime Video and Bloomberg TV, increasing awareness about innovative breast imaging technologies.
